silybin has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Hou, JW; Li, YG; Lin, H; Mao, ZJ; Wang, Q | 1 |
| Dai, Y; Meng, J; Wan, X; Yan, S; Zhang, Y | 1 |
2 other study(ies) available for silybin and Myocardial Ischemia
| Article | Year |
|---|---|
Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction.
Topics: Animals; Caspases; Cell Line; Cell Survival; Gene Expression Regulation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocytes, Cardiac; Nitriles; Protective Agents; Reactive Oxygen Species; Reperfusion Injury; Silybin; Sulfones | 2020 |
Visualization of network target crosstalk optimizes drug synergism in myocardial ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Celecoxib; Cells, Cultured; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Molecular Targeted Therapy; Myocardial Ischemia; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Sulfonamides | 2014 |